Every Thursday we send out a curated newsletter on all things femtech and women’s health innovation. This is an excerpt from the latest edition. If you’d like to subscribe, you can do so at the bottom of this page.
Highlights
Juniper Genomics raises $4.6M for whole-genome embryo screening platform.
Chinese premium postpartum care provider Saint Bella Group goes public.
Escala Medical raises $4.5M for pelvic organ prolapse treatment device.
Beech Biotech receives $1.9M Gates Foundation grant for novel preeclampsia treatment.
Sama Fertility launches first at-home IVF protocol in the United States.
Aspivix expands European presence with distribution partnerships across the UK and Benelux regions.
Journey pregnancy app integratesFaceHeart’s FDA-cleared mobile vitals scanner.
Lilli Health launches new PCOS management app targeting insulin resistance.
Organon discontinues endometriosis drug development after failed Phase 2 trial.
In the Know
Why Mark Cuban Thinks You Should Invest in Women’s Health (Femtech Insider)
I’m a social media scientist with 3.5 Million followers. Here’s what I’ve learned about public health communication (STAT News)
Doctors don’t get much menopause training. State lawmakers are trying to change that (NPR)
The climate crisis is a sexual health and reproductive rights emergency (Salon)
Autistic people’s experiences of periods are under-researched – here’s why that needs to change (The Conversation)
How a computer scientist is using AI to save mothers’ lives in Pakistan (Gates Foundation)
Who’s Hiring?
Below are some jobs we’ve curated for the women’s health innovation community this week.
Vella Bioscience is looking for a Junior Visual Designer.
Twentyeight Health is hiring a Clinical Lead.
Everly Health is hiring a Director of AI and Data Engineering.
Hims & Hers is looking for a Medical Content Reviewer.
Flo Health is looking for a Senior Marketing Copywriter.
Organon is hiring a Senior Brand & Customer Manager.
Maven Clinic is looking for a SVP, Product.
To view more roles, visit our job board.
